Summary of the 2026 Stock Option Incentive Plan (Draft) of Guangdong Lifesense Medical Electronic Co., Ltd.

Securities Abbreviation: Lifesense Medical

Securities Code: 300562

[Chart: Lifesense Logo]

Guangdong Lifesense Medical Electronic Co., Ltd.

2026 Stock Option Incentive Plan (Draft) Summary

July 2026

Statement

The Company and all members of the Board of Directors guarantee that the contents of this incentive plan and its summary are true, accurate, and complete, with no false records, misleading statements, or major omissions.

Special Notice

1. The 2026 Stock Option Incentive Plan (Draft) of Guangdong Lifesense Medical Electronic Co., Ltd. (hereinafter referred to as "Lifesense Medical," "the Company," or "this Company") is formulated in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for Equity Incentives of Listed Companies, the Shenzhen Stock Exchange GEM Listed Company Self-Regulatory Guidelines No. 1—Business Handling, and other relevant laws, administrative regulations, normative documents, and the Articles of Association.

2. The incentive form adopted by the Lifesense Medical 2026 Stock Option Incentive Plan (hereinafter referred to as "this Incentive Plan") is stock options. The source of the stock is the Company's RMB A-share common stock issued to the incentive targets.

3. The number of stock options proposed to be granted to the incentive targets under this Incentive Plan is 3.00 million units, accounting for approximately 1.37% of the Company's total share capital of 218.613688 million shares on the date of the announcement of the draft incentive plan. Each stock option granted under this plan grants the right to purchase 1 share of the Company's RMB A-share common stock at the exercise price during the exercise period, provided that the vesting conditions and arrangements are met. This grant is a one-time grant with no reserved interests.

As of the date of the announcement of this draft incentive plan, the total number of underlying shares involved in all of the Company's equity incentive plans within the validity period does not exceed 20.00% of the Company's total share capital. The number of company shares granted to any single incentive target through all equity incentive plans within the validity period does not exceed 1.00% of the Company's total share capital.

1. The total number of incentive targets involved in this Incentive Plan is 43, including directors, senior management, and core technical/business personnel serving in the Company (including branches and holding subsidiaries) at the time of the announcement of this Incentive Plan, excluding independent directors, shareholders or actual controllers who individually or collectively hold more than 5% of the Company's shares, and their spouses, parents, and children.

2. The exercise price of the stock options granted under this Incentive Plan is 14.37 yuan/unit. From the date of the announcement of the draft incentive plan to the completion of the exercise of the stock options by the incentive targets, if the Company undergoes capital reserve capitalization, stock dividends, stock splits, share consolidations, rights issues, or dividend distributions, the exercise price and the number of equity interests will be adjusted accordingly in accordance with this Incentive Plan.

3. The validity period of this Incentive Plan shall commence from the date of the stock option grant and end on the date when all stock options granted to the incentive targets are exercised or cancelled, not exceeding 36 months.

4. The stock options granted under this Incentive Plan shall be exercised in two batches after 12 months from the date of grant, with an exercise ratio of 50% and 50% for each batch.

The company-level performance assessment targets for the stock options granted under this Incentive Plan are shown in the table below: